Surfix develops a test method for corona diagnosis

Surfix, located at Wageningen Campus, together with their Dutch partners Lionix International and Qurin Diagnostics and supported by public-private partnership Photon Delta develops a test method for corona diagnosis and immunity detection.

The aim is to have SARS-CoV-2 testing devices in doctors’ offices, which yield reliable test results within 5 minutes.

Surfix was founded in 2011 as a spin-off of the Organic Chemistry laboratory of Wageningen University & Research and is located in Plus Ultra on Wageningen Campus.
Read more
7 January 2021|